Fibrinogen replacement in trauma haemorrhage: essential but not empirical?
Emerg Med J
.
2024 Jun 20;41(7):447-448.
doi: 10.1136/emermed-2024-213925.
Authors
Ross Davenport
1
2
,
Nicola Curry
3
4
Affiliations
1
Centre for Trauma Sciences, Blizard Institute, Queen Mary University of London, London, UK ross.davenport@qmul.ac.uk.
2
Royal London Major Trauma Centre, Barts Health NHS Trust, London, UK.
3
Radcliffe Department of Medicine, Oxford University, Oxford, UK.
4
Oxford Haemophilia and Thrombosis Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
PMID:
38782557
DOI:
10.1136/emermed-2024-213925
No abstract available
Keywords:
Randomized Controlled Trial; critical care; hematology; resuscitation; trauma.
Publication types
Editorial
MeSH terms
Fibrinogen* / therapeutic use
Hemorrhage* / drug therapy
Humans
Wounds and Injuries* / complications
Substances
Fibrinogen
Grants and funding
MR/T023961/1/MRC_/Medical Research Council/United Kingdom